BioRestorative Therapies Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| BAX | Baxter International Inc | Hold |
17
|
$35.24 | $44.86 | 24.86% | 5 | $17.96B |
| VCEL | Vericel | Buy |
8
|
$48.53 | $42.58 | 15.39% | 0 | $2.36B |
| GERN | Geron | Outperform |
6
|
$3.68 | $4.83 | 35.87% | 1 | $2.30B |
| LCTX | Lineage Cell Therapeutics | Outperform |
11
|
$1.04 | $5.40 | 380.77% | 1 | $220.89M |
| MSB | Mesoblast | Buy |
9
|
$1.07 | $0.69 | 2.80% | 0 | $299.37M |
| LSTA | Lisata Therapeutics | Buy |
8
|
$2.96 | $16.00 | 389.86% | 2 | $22.85M |
| PSTV | Plus Therapeutics | Buy |
11
|
$2.17 | $11.00 | 591.24% | 2 | $9.71M |